Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2021 Annual Report with Sustainability Disclosures
Company: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Sector: Manufacturing
Country: China
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 263
The report describes a year of strong growth, with Group revenue reaching approximately RMB1,140.3 million and R&D investment reaching RMB248.2 million. It includes a dedicated ESG Report covering the Group's main businesses and reports 14,978.55 MWh of total energy consumption. The company reports no work-related fatalities in the past three reporting periods and highlights charitable donations, medicine donations, and rural poverty-alleviation activities.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.